{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-26-073847","form_type":"8-K","ticker":"ESLA","cik":"0001844417","company_name":"Estrella Immunopharma, Inc.","filed_at":"2026-06-30T21:29:37+00:00","discovered_at":"2026-06-30T21:32:00.301593+00:00","generated_at":"2026-06-30T21:32:15.541100+00:00","sec_items":["5.07"],"event_type":"other","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"high","headline":"Estrella Immunopharma stockholders ratify auditor at 2025/2026 annual meeting","bullets":["Ratified Macias Gini & O'Connell LLP as independent auditor for fiscal year ending Dec 31, 2026.","Votes: 30,351,203 for, 400 against, 5 abstain; no broker non-votes.","Annual meeting held June 29, 2026; quorum of ~70.5% of outstanding shares."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-26-073847","json":"https://secwatch.observer/filing/0001213900-26-073847.json","markdown":"https://secwatch.observer/filing/0001213900-26-073847.md","text":"https://secwatch.observer/filing/0001213900-26-073847.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1844417/000121390026073847/0001213900-26-073847-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1844417/000121390026073847/ea029661701-8k_estrella.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-30T21:32:15.541100+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}